Document is current
Any future updates will be listed below
-
Authors
Muehlensiepen, Felix https://orcid.org/0000-0001-8571-7286
May, Susann https://orcid.org/0000-0002-3601-7432
Hadaschik, Katharina
Vuillerme, Nicolas https://orcid.org/0000-0003-3773-393X
Heinze, Martin https://orcid.org/0000-0003-3645-1033
Grahammer, Manuel https://orcid.org/0000-0003-1560-4459
Labinsky, Hannah
Boeltz, Sebastian https://orcid.org/0000-0001-5227-8707
Detert, Jacqueline
Petersen, Jana
Krönke, Gerhard https://orcid.org/0000-0002-7566-4325
Schett, Georg https://orcid.org/0000-0001-8740-9615
Knitza, Johannes https://orcid.org/0000-0001-9695-0657
-
Funding
Funding for this research was provided by:
Abaton GmbH
Deutsche Forschungsgemeinschaft (2886)
Medizinische Hochschule Brandenburg CAMPUS gGmbH
- License Information
-
More Information
Article History
Received: 26 August 2022
Accepted: 27 September 2022
First Online: 14 October 2022
Declarations
:
: JK reports personal fees from ABATON GmbH. MG is founder and shareholder of ABATON GmbH. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This prospective trial was registered in the WHO International Clinical Trials Registry (DRKS00024205) on 2021/03/03 and approved by Ethics Committee of the Friedrich-Alexander University Erlangen-Nuremberg (Reg no. 21_21B) on 2021/02/03). Written informed consent was obtained from all study participants. All methods were performed in accordance with relevant guidelines and regulations/declaration of Helsinki. Informed consent was obtained from all subjects and/or their legal guardian(s) for study participation. This manuscript has been compiled in accordance with the Consolidated Criteria for Reporting Qualitative Research (COREQ) (Supplemental File 4).
